Published in World J Surg Oncol on March 13, 2014
Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma. World J Surg Oncol (2015) 0.78
Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer. Int J Clin Exp Pathol (2014) 0.77
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res (2004) 3.90
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer (1996) 2.95
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA (2003) 2.24
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol (2008) 2.14
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer. Ann Oncol (2012) 2.06
Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. J Clin Oncol (2009) 1.77
Multicentricity and bilaterality in invasive breast carcinoma. Surgery (1982) 1.69
Infiltrating lobular carcinoma of the breast. Cancer (1973) 1.47
Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer (1997) 1.46
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer (2007) 1.46
Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer (2000) 1.45
Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update. J Surg Oncol (2008) 1.39
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol (2010) 1.31
Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat (2012) 1.11
Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management. Arch Surg (1979) 1.06
The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat (2000) 1.03
Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period. Ann Surg Oncol (2011) 1.00
Brain metastases and subtypes of breast cancer. Ann Oncol (2009) 0.97
Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg (1983) 0.94
Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol (1995) 0.94
Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study. World J Surg Oncol (2010) 0.90
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer (2006) 0.88
Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol (1997) 0.86
Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg (1997) 0.86
Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial. J Clin Oncol (2013) 0.84
Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J (2007) 0.83
Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population. World J Surg Oncol (2012) 0.82
[Determination of HER2 by fluorescence in situ hybridization (FISH) in breast cancer. Experience of the Reference Laboratory of Lisbon]. Acta Med Port (2006) 0.82
Mammographic detection and staging of invasive lobular carcinoma. Clin Imaging (2006) 0.80
Clinical impacts of histological subtyping primary breast cancer. Anticancer Res (2010) 0.79
Distinct clinical and prognostic features of invasive lobular breast cancer. Breast Dis (2012) 0.77
Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer (2011) 1.92
Eccrine spiradenoma arising in the breast misdiagnosed as an epidermal inclusion cyst. Korean J Radiol (2011) 1.00
Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol (2010) 0.98
Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells. Nucleic Acids Res (2013) 0.95
High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Cancer Lett (2012) 0.93
Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Korean Med Sci (2004) 0.93
Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer. Breast Cancer Res Treat (2014) 0.89
Metastasis to the breast from colonic adenocarcinoma. J Korean Surg Soc (2011) 0.89
Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets. Ann Surg Oncol (2014) 0.88
Long-term results after excision of breast mass using a vacuum-assisted biopsy device. ANZ J Surg (2009) 0.88
Lymphoepithelioma-like carcinoma of the breast. J Ultrasound Med (2010) 0.87
Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer. BMC Cancer (2014) 0.87
Breast sonographic elastography using an advanced breast tissue-specific imaging preset: initial clinical results. J Ultrasound Med (2012) 0.86
Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer. Breast Cancer Res Treat (2011) 0.84
Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer. Med Oncol (2014) 0.84
Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea. Fam Cancer (2014) 0.84
The current status of endoscopic thyroidectomy in Korea. Surg Laparosc Endosc Percutan Tech (2008) 0.84
Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer. J Korean Med Sci (2004) 0.83
The Risk Factors Influencing between the Early and Late Recurrence in Systemic Recurrent Breast Cancer. J Breast Cancer (2012) 0.83
Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society. Ann Surg Oncol (2013) 0.81
[A case of gastric ulcer induced by Helicobacter heilmannii-like organism]. Korean J Gastroenterol (2003) 0.81
A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts. Ann Nucl Med (2012) 0.81
Bfl-1 gene expression in breast cancer: its relationship with other prognostic factors. J Korean Med Sci (2003) 0.81
Benign retroperitoneal schwannoma: surgical consideration. Hepatogastroenterology (2005) 0.81
Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. Cancer Res Treat (2012) 0.80
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes. Breast Cancer Res Treat (2015) 0.80
Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort. Breast Cancer Res Treat (2013) 0.80
Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis. Oncology (2015) 0.79
Risk factor for axillary lymph node metastases in microinvasive breast cancer. Ann Surg Oncol (2011) 0.79
The value of chest CT for prediction of breast tumor size: comparison with pathology measurement. World J Surg Oncol (2013) 0.79
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women. J Cancer Res Clin Oncol (2014) 0.79
Secretory carcinoma of the breast. J Clin Ultrasound (2003) 0.78
Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy. Ann Surg Oncol (2014) 0.78
Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients. J Thorac Oncol (2012) 0.78
Leptin as a potential target for estrogen receptor-positive breast cancer. J Breast Cancer (2013) 0.78
Invasive ductal carcinoma arising from dense accessory breast visualized with 99mTc-MIBI breast-specific γ imaging. Clin Nucl Med (2014) 0.77
Expression of AITR and AITR ligand in breast cancer patients. Oncol Rep (2007) 0.76
Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer. Medicine (Baltimore) (2016) 0.76
TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2. J Chemother (2015) 0.75
Lipogranuloma with osseous metaplasia in the breast that developed after "Bu-Hwang" oriental medicine treatment. Yonsei Med J (2011) 0.75
Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2014) 0.75
Follow-up bone scan in breast cancer patients: what is the appropriate interpretation of purely rib uptake? Nucl Med Commun (2016) 0.75
Primary neuroendocrine carcinoma of the breast involving the nipple-areolar complex. J Ultrasound Med (2008) 0.75
Intensive postoperative surveillance using chest CT and bone scan in patients with locally advanced breast cancer. Breast J (2014) 0.75